In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among eCOA providers, the importance of sponsor involvement, and the challenges of validated translations. Explore the complexities that can arise in these critical aspects of clinical trials
Tune in to our chat with Aaron McCormick, Associate Director, eCOA Implementation at Moderna, to unravel the importance of standardized eCOA systems across trials...
Artificial intelligence is redefining what’s possible across the clinical development lifecycle, but with rapid innovation comes the need for thoughtful oversight. In this episode...
In our first episode of LifeSci Talks, Global Practice Leader & COA SME of TransPerfect Life Sciences sits down with Dr. Elin Haf Davies,...
